Clinical Trials Browser

Recruiting × lenvatinib × Tumor-Agnostic × Clear all

NCT06669572 2026-02-17

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Phase 2 Recruiting

Carcinoma, Squamous Cell

NCT05767684 2023-08-25

Neoantigen Derived DCs as Cancer Treatment

Phase 1 Recruiting

Neoplasms